Evidence map›Paper›PMID 38361824›Full record

ArticleVirus evolution2024

SARS-CoV-2 infection in immunosuppression evolves sub-lineages which independently accumulate neutralization escape mutations.

Gila Lustig, Yashica Ganga, Hylton E Rodel, Houriiyah Tegally, Afrah Khairallah, Laurelle Jackson, Sandile Cele, Khadija Khan, Zesuliwe Jule, Kajal Reedoy and 10 more

Open access · goldAbstract read
In one paragraph

Article in Virus evolution, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 4 countries.

Gila LustigCentre for the AIDS Programme of Research in South Africa, 719 Umbilo Road, Durban 4001, South Africa.
Yashica GangaAfrica Health Research Institute, 719 Umbilo Road, Durban 4001, South Africa.
Hylton E RodelAfrica Health Research Institute, 719 Umbilo Road, Durban 4001, South Africa.
Houriiyah TegallyKwaZulu-Natal Research Innovation and Sequencing Platform, 719 Umbilo Road, Durban 4001, South Africa.ORCID https://orcid.org/0000-0002-7102-8540
Afrah KhairallahAfrica Health Research Institute, 719 Umbilo Road, Durban 4001, South Africa.
Laurelle JacksonAfrica Health Research Institute, 719 Umbilo Road, Durban 4001, South Africa.
Sandile CeleAfrica Health Research Institute, 719 Umbilo Road, Durban 4001, South Africa.
Khadija KhanAfrica Health Research Institute, 719 Umbilo Road, Durban 4001, South Africa.
Zesuliwe JuleAfrica Health Research Institute, 719 Umbilo Road, Durban 4001, South Africa.
Kajal ReedoyAfrica Health Research Institute, 719 Umbilo Road, Durban 4001, South Africa.
Farina KarimAfrica Health Research Institute, 719 Umbilo Road, Durban 4001, South Africa.
Mallory BernsteinAfrica Health Research Institute, 719 Umbilo Road, Durban 4001, South Africa.ORCID https://orcid.org/0000-0001-7498-2391
Thumbi Ndung'uAfrica Health Research Institute, 719 Umbilo Road, Durban 4001, South Africa.
Mahomed-Yunus S MoosaDepartment of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, 719 Umbilo Road, Durban 4001, South Africa.ORCID https://orcid.org/0000-0001-6191-4023
Derseree ArcharyCentre for the AIDS Programme of Research in South Africa, 719 Umbilo Road, Durban 4001, South Africa.
Tulio de OliveiraKwaZulu-Natal Research Innovation and Sequencing Platform, 719 Umbilo Road, Durban 4001, South Africa.ORCID https://orcid.org/0000-0002-3027-5254
Richard LessellsKwaZulu-Natal Research Innovation and Sequencing Platform, 719 Umbilo Road, Durban 4001, South Africa.
Richard A NeherSIB Swiss Institute of Bioinformatics, Quartier Sorge - Bâtiment Amphipôle, Lausanne 1015, Switzerland.ORCID https://orcid.org/0000-0003-2525-1407
Salim S Abdool KarimCentre for the AIDS Programme of Research in South Africa, 719 Umbilo Road, Durban 4001, South Africa.
Alex SigalCentre for the AIDS Programme of Research in South Africa, 719 Umbilo Road, Durban 4001, South Africa.ORCID https://orcid.org/0000-0001-8571-2004
Africa Health Research Institute · ZACentre for the AIDS Programme of Research in South Africa · ZARagon Institute of MGH, MIT and Harvard · USSIB Swiss Institute of Bioinformatics · CHStellenbosch University · ZAUniversity of Basel · CHUniversity of KwaZulu-Natal · ZAUniversity of Washington · US

Funding

Gates Foundation INV-018944Wellcome Trust
6 · The paper itself

Abstract

One mechanism of variant formation may be evolution during long-term infection in immunosuppressed people. To understand the viral phenotypes evolved during such infection, we tested SARS-CoV-2 viruses evolved from an ancestral B.1 lineage infection lasting over 190 days post-diagnosis in an advanced HIV disease immunosuppressed individual. Sequence and phylogenetic analysis showed two evolving sub-lineages, with the second sub-lineage replacing the first sub-lineage in a seeming evolutionary sweep. Each sub-lineage independently evolved escape from neutralizing antibodies. The most evolved virus for the first sub-lineage (isolated day 34) and the second sub-lineage (isolated day 190) showed similar escape from ancestral SARS-CoV-2 and Delta-variant infection elicited neutralizing immunity despite having no spike mutations in common relative to the B.1 lineage. The day 190 isolate also evolved higher cell-cell fusion and faster viral replication and caused more cell death relative to virus isolated soon after diagnosis, though cell death was similar to day 34 first sub-lineage virus. These data show that SARS-CoV-2 strains in prolonged infection in a single individual can follow independent evolutionary trajectories which lead to neutralization escape and other changes in viral properties.

Indexed as

advanced HIV diseaseimmunosuppressionprolonged infectionSARS-CoV-2 evolutionvariants of concern

Identifiers

PMID38361824
PMCPMC10868398
OpenAlexW4390401986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.